Related Experiment Video
Updated: May 20, 2026
09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
Antithrombotic therapy for secondary stroke prevention.
Continuum (Minneapolis, Minn.)
|July 20, 2012
Summary
Choosing the right antithrombotic therapy, such as antiplatelets or anticoagulants, is crucial for preventing recurrent ischemic strokes. Newer medications offer improved adherence and safety profiles compared to older treatments.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Antithrombotic therapy is essential for secondary prevention of ischemic stroke.
- Understanding therapeutic options improves stroke prevention, adherence, and reduces complications.
Purpose of the Study:
- To review current antithrombotic therapies for ischemic stroke secondary prevention.
- To highlight the benefits of newer agents and guide clinical decision-making.
Main Methods:
- Review of antiplatelet agents and anticoagulants for stroke prevention.
- Analysis of the PRoFESS study comparing clopidogrel and aspirin plus extended-release dipyridamole.
- Evaluation of new oral anticoagulants (dabigatran, apixaban) versus warfarin.
Main Results:
- Clopidogrel and aspirin plus extended-release dipyridamole showed similar recurrent stroke rates, with clopidogrel better tolerated and causing fewer bleeds.
- New oral anticoagulants like dabigatran and apixaban may replace warfarin for atrial fibrillation-related stroke prevention.
- These newer agents offer easier use, potentially better efficacy and safety, fewer interactions, and no need for routine monitoring.
Conclusions:
- Optimal antithrombotic selection requires considering patient affordability, tolerance, side effects, and adherence.
- Proper medication use guided by current guidelines is expected to reduce recurrent stroke risk.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...